These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12924341)

  • 21. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia.
    Musher DM; Rueda-Jaimes AM; Graviss EA; Rodriguez-Barradas MC
    Clin Infect Dis; 2006 Oct; 43(8):1004-8. PubMed ID: 16983612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine doesn't lower pneumonia risk in the elderly.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 May; 14(10):8-9. PubMed ID: 12870488
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals.
    Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
    Clin Infect Dis; 2007 Feb; 44(4):617; author reply 617-8. PubMed ID: 17260423
    [No Abstract]   [Full Text] [Related]  

  • 25. Missed opportunities in vaccination of patients with subsequent pneumococcal bacteraemia.
    Weightman NC; Walters A
    Br J Gen Pract; 2003 Jul; 53(492):547-9. PubMed ID: 14694668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pneumococcal vaccine development.
    Poolman JT
    Expert Rev Vaccines; 2004 Oct; 3(5):597-604. PubMed ID: 15485339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pneumococcal vaccination on hospitalization and exacerbations in elderly Japanese chronic obstructive pulmonary disease patients.
    Yamaya M; Fujino N; Kubo H; Arai H
    Geriatr Gerontol Int; 2009 Jun; 9(2):206-9. PubMed ID: 19490143
    [No Abstract]   [Full Text] [Related]  

  • 29. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia.
    Kruspe R; Lillis R; Daberkow DW; Blais CM; Wilbright W; Gupta S; Gould CA; Sun T; Martinez JA; deBoisblanc B; Ladabaum U; Sanders CV; Lopez FA
    J La State Med Soc; 2003; 155(6):325-31. PubMed ID: 14750752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
    Bergman A; Hjelmgren J; Ortqvist A; Wisløff T; Kristiansen IS; Högberg LD; Persson KM; Persson U
    Scand J Infect Dis; 2008; 40(9):721-9. PubMed ID: 18712627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fulminating pneumococcal septicemia in a 2 year old child with sickle cell anemia].
    Visser M; Hogeman PH; van Vught AJ; Révész T; Wolfs TF
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):454-6. PubMed ID: 12666518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumococcal vaccine is clinically effective].
    Konradsen HB
    Ugeskr Laeger; 2001 Nov; 163(48):6771-4. PubMed ID: 11768910
    [No Abstract]   [Full Text] [Related]  

  • 33. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
    Albrich WC; Baughman W; Schmotzer B; Farley MM
    Clin Infect Dis; 2007 Jun; 44(12):1569-76. PubMed ID: 17516400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65.
    Whitney CG
    Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotypes and pathogens in paediatric pneumonia.
    Hausdorff WP; Dagan R
    Vaccine; 2008 Jun; 26 Suppl 2():B19-23. PubMed ID: 18793602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
    Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
    Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumococcal polysaccharide vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 Aug; 30(33):410-2, 417-9. PubMed ID: 6792481
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical inquiries. Which asthma patients should get the pneumococcal vaccine?
    Harris JB; Edgerton L; Stafford K
    J Fam Pract; 2009 Nov; 58(11):611-2. PubMed ID: 19891942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.